Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$18.93 -1.3%	$19.68	$13.74 ▼ $35.56	$158.75M	0.38	83,048 shs	63,582 shs
LNSR LENSAR	$12.65 +1.2%	$12.86	$3.80 ▼ $17.31	$150.98M	0.5	57,859 shs	63,957 shs
PROF Profound Medical	$4.25 -23.3%	$5.91	$3.89 ▼ $9.87	$127.73M	0.52	23,901 shs	613,265 shs
TMDIF Titan Medical	$0.33 -5.3%	$0.32	$0.03 ▼ $1.00	$3.73M	1.26	74,785 shs	26,840 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	0.00%	+1.56%	+1.50%	-12.16%	+31.92%
LNSR LENSAR	0.00%	-1.71%	-4.09%	-10.35%	+215.46%
PROF Profound Medical	0.00%	-23.29%	-25.44%	-9.77%	-54.35%
TMDIF Titan Medical	-11.73%	-9.67%	-12.11%	+6.48%	+778.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ELMD Electromed	1.2088 of 5 stars	2.0	3.0	0.0	0.0	0.0	1.7	1.3
LNSR LENSAR	1.0487 of 5 stars	2.0	1.0	0.0	0.0	2.9	2.5	0.0
PROF Profound Medical	1.7683 of 5 stars	3.5	1.0	0.0	0.0	1.8	0.8	0.6
TMDIF Titan Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELMD Electromed	4.00	Strong Buy	$33.50	76.97% Upside
LNSR LENSAR	2.00	Hold	$15.00	18.58% Upside
PROF Profound Medical	3.00	Buy	$11.00	158.82% Upside
TMDIF Titan Medical	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest TMDIF, PROF, ELMD, and LNSR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/22/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00
7/21/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELMD Electromed	$61.44M	2.58	$0.46 per share	41.36	$5.10 per share	3.71
LNSR LENSAR	$58.36M	2.59	N/A	N/A	($1.93) per share	-6.55
PROF Profound Medical	$11.86M	10.77	N/A	N/A	$2.01 per share	2.11
TMDIF Titan Medical	$17.63M	2.10	$16.26 per share	0.02	$1.05 per share	0.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELMD Electromed	$5.15M	$0.79	25.24	∞	N/A	11.34%	15.71%	13.37%	N/A
LNSR LENSAR	-$31.40M	-$4.21	N/A	∞	N/A	-84.49%	-737.30%	-72.60%	N/A
PROF Profound Medical	-$27.82M	-$1.46	N/A	N/A	N/A	-343.97%	-85.88%	-70.49%	N/A
TMDIF Titan Medical	$6.95M	$0.05	N/A	∞	N/A	N/A	-82.31%	-51.47%	N/A

Latest TMDIF, PROF, ELMD, and LNSR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	PROF Profound Medical	-$0.43	-$0.52	-$0.09	-$0.52	$4.75 million	$2.21 million
8/7/2025	Q2 2025	LNSR LENSAR	-$0.0750	-$0.15	-$0.0750	-$0.15	$16.55 million	$11.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
TMDIF Titan Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELMD Electromed	N/A	5.10	4.74
LNSR LENSAR	N/A	1.52	0.88
PROF Profound Medical	0.09	11.31	10.03
TMDIF Titan Medical	N/A	3.73	3.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELMD Electromed	40.82%
LNSR LENSAR	40.15%
PROF Profound Medical	47.86%
TMDIF Titan Medical	0.03%

Insider Ownership

Company	Insider Ownership
ELMD Electromed	14.00%
LNSR LENSAR	38.52%
PROF Profound Medical	1.52%
TMDIF Titan Medical	0.02%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELMD Electromed	160	8.39 million	7.36 million	Optionable
LNSR LENSAR	110	11.94 million	7.34 million	Optionable
PROF Profound Medical	150	30.05 million	29.60 million	Optionable
TMDIF Titan Medical	50	114.04 million	4.56 million	Not Optionable

TMDIF, PROF, ELMD, and LNSR Headlines

Recent News About These Companies

Titan Medical Group Launches Titan Workforce Solutions: Launches to Transform Healthcare Staffing

April 29, 2025 | businesswire.com

Titan Nurse Staffing, LLC and Titan Medical Group, LLC Announce Merger to Streamline Healthcare Staffing Services

April 29, 2025 | businesswire.com

Titan MRI acquires High Field MRI, expanding Titan MRI's service to North Central Florida

December 3, 2024 | msn.com

Attack on Titan movie release date, trailer, changes, and everything else we know about The Last Attack

November 6, 2024 | gamesradar.comG

Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

October 11, 2024 | globenewswire.com

Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction

October 8, 2024 | globenewswire.com

Titan Announces Resignations of Directors

October 2, 2024 | globenewswire.com

Titan Reports Voting Results from 2023 Annual General and Special Meeting

September 30, 2024 | globenewswire.com

Titan Medical begins process to move to the TSX Venture Exchange

September 30, 2024 | globenewswire.com

Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi

September 26, 2024 | globenewswire.com

Proxy Deadline Thursday September 26, 2024

September 25, 2024 | globenewswire.com

Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

September 19, 2024 | globenewswire.com

A key employee says the Titan sub tragedy could have been prevented

September 18, 2024 | postregister.comP

Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

September 16, 2024 | globenewswire.com

Titan Announces Conavi Medical to Present Overview at Titan Q&A Session

September 16, 2024 | globenewswire.com

Titan Announces Q&A Session with Shareholders

September 9, 2024 | globenewswire.com

Titan Announces Filing of the Management Information Circular.

September 6, 2024 | globenewswire.com

Titan Medical | Morning Blend

September 3, 2024 | msn.com

Titan Medical Inc. (QTNA.SG)

August 24, 2024 | finance.yahoo.com

Titan Medical Reports Operating and Financial Results for the Second Quarter 2024

August 15, 2024 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TMDIF, PROF, ELMD, and LNSR Company Descriptions

Electromed NYSE:ELMD

$18.93 -0.24 (-1.25%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$18.86 -0.07 (-0.34%)

As of 08/15/2025 04:04 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

LENSAR NASDAQ:LNSR

$12.65 +0.15 (+1.20%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$13.22 +0.57 (+4.54%)

As of 08/15/2025 05:52 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Profound Medical NASDAQ:PROF

$4.25 -1.29 (-23.29%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$4.49 +0.24 (+5.53%)

As of 08/15/2025 05:13 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Titan Medical NASDAQ:TMDIF

$0.33 -0.02 (-5.27%)

As of 08/15/2025

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time